Retinoid X Receptor Heterodimers in Hepatic Function: Structural Insights and Therapeutic Potential

Overview

Journal Front Pharmacol

Date 2024 Oct 31

PMID 39478961

Authors

Renjie Xu

Linyue Zhang

Hao Pan

Yong Zhang

Affiliations

Soon will be listed here.

Abstract

Nuclear receptors (NRs) are key regulators of multiple physiological functions and pathological changes in the liver in response to a variety of extracellular signaling changes. Retinoid X receptor (RXR) is a special member of the NRs, which not only responds to cellular signaling independently, but also regulates multiple signaling pathways by forming heterodimers with various other NR. Therefore, RXR is widely involved in hepatic glucose metabolism, lipid metabolism, cholesterol metabolism and bile acid homeostasis as well as hepatic fibrosis. Specific activation of particular dimers regulating physiological and pathological processes may serve as important pharmacological targets. So here we describe the basic information and structural features of the RXR protein and its heterodimers, focusing on the role of RXR heterodimers in a number of physiological processes and pathological imbalances in the liver, to provide a theoretical basis for RXR as a promising drug target.

References

Jin X, Peng D, Kim S, Kim N, Nejad J, Kim D . Vitamin A supplementation downregulates and mRNA expression in weaned beef calves. Anim Nutr. 2022; 10:372-381. PMC: 9356019. DOI: 10.1016/j.aninu.2022.06.007. View

Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris T . Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature. 2008; 456(7220):350-6. PMC: 2743566. DOI: 10.1038/nature07413. View

Lebovitz H . Thiazolidinediones: the Forgotten Diabetes Medications. Curr Diab Rep. 2019; 19(12):151. PMC: 6881429. DOI: 10.1007/s11892-019-1270-y. View

Luo J, Yang H, Song B . Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2019; 21(4):225-245. DOI: 10.1038/s41580-019-0190-7. View

Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T . Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 1992; 68(2):377-95. DOI: 10.1016/0092-8674(92)90478-u. View

Jia W, Wei M, Rajani C, Zheng X . Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2020; 12(5):411-425. PMC: 8106556. DOI: 10.1007/s13238-020-00804-9. View

Izu-Belloso R, Gainza-Apraiz I, Ortiz-Romero P, Servitje-Bedate O, Fernandez de Misa-Cabrera R, Penate Y . Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas. Actas Dermosifiliogr. 2024; 115(6):547-554. DOI: 10.1016/j.ad.2023.12.007. View

Wang J, Zhang M, Luo M, Qin S, Xia X . Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. Sci Rep. 2022; 12(1):18873. PMC: 9640703. DOI: 10.1038/s41598-022-23539-5. View

Takahashi Y, Inoue J, Kagechika H, Sato R . ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists. FEBS Lett. 2009; 583(2):493-7. DOI: 10.1016/j.febslet.2008.12.050. View

10.

Gampe Jr R, Montana V, Lambert M, Miller A, Bledsoe R, Milburn M . Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell. 2000; 5(3):545-55. DOI: 10.1016/s1097-2765(00)80448-7. View

11.

Egea P, Mitschler A, Moras D . Molecular recognition of agonist ligands by RXRs. Mol Endocrinol. 2002; 16(5):987-97. DOI: 10.1210/mend.16.5.0823. View

12.

Wongsiriroj N, Jiang H, Piantedosi R, Yang K, Kluwe J, Schwabe R . Genetic dissection of retinoid esterification and accumulation in the liver and adipose tissue. J Lipid Res. 2013; 55(1):104-14. PMC: 3927479. DOI: 10.1194/jlr.M043844. View

13.

Cassim Bawa F, Xu Y, Gopoju R, Plonski N, Shiyab A, Hu S . Hepatic retinoic acid receptor alpha mediates all-trans retinoic acid's effect on diet-induced hepatosteatosis. Hepatol Commun. 2022; 6(10):2665-2675. PMC: 9512485. DOI: 10.1002/hep4.2049. View

14.

Cai X, Young G, Xie W . The xenobiotic receptors PXR and CAR in liver physiology, an update. Biochim Biophys Acta Mol Basis Dis. 2021; 1867(6):166101. PMC: 8026720. DOI: 10.1016/j.bbadis.2021.166101. View

15.

Wang Y, Zhang Z, Yao R, Jia D, Wang D, Lubet R . Prevention of lung cancer progression by bexarotene in mouse models. Oncogene. 2005; 25(9):1320-9. DOI: 10.1038/sj.onc.1209180. View

16.

Lu J, Shang X, Yao B, Sun D, Liu J, Zhang Y . The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia. Acta Pharm Sin B. 2023; 13(2):648-661. PMC: 9978856. DOI: 10.1016/j.apsb.2022.08.005. View

17.

Ticho A, Malhotra P, Dudeja P, Gill R, Alrefai W . Intestinal Absorption of Bile Acids in Health and Disease. Compr Physiol. 2019; 10(1):21-56. PMC: 7171925. DOI: 10.1002/cphy.c190007. View

18.

Paul S, Gangwar A, Bhargava K, Ahmad Y . STAT3-RXR-Nrf2 activates systemic redox and energy homeostasis upon steep decline in pO gradient. Redox Biol. 2017; 14:423-438. PMC: 5680518. DOI: 10.1016/j.redox.2017.10.013. View

19.

Lopaschuk G, Karwi Q, Tian R, Wende A, Abel E . Cardiac Energy Metabolism in Heart Failure. Circ Res. 2021; 128(10):1487-1513. PMC: 8136750. DOI: 10.1161/CIRCRESAHA.121.318241. View

20.

Funaki M, Kitabayashi J, Shimakami T, Nagata N, Sakai Y, Takegoshi K . Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo. Sci Rep. 2017; 7(1):16978. PMC: 5717167. DOI: 10.1038/s41598-017-17285-2. View